Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Placebo Controlled, Double Blind, Parallel Group Multi-Center Study In Order To Investigate Safety And Efficacy Of CP- 690 550 In Subjects With Moderate To Severe Ulcerative Colitis.
Brief Summary: The hypothesis of the study is that at least one dose of CP 690 550 is superior to placebo (inactive drug) in inducing remission in patients with moderate to severe ulcerative colitis.


Options:
A: Arm Label: 15 mg BID; Type: EXPERIMENTAL; Interventions: Drug: CP- 690 550 | Arm Label: 10 mg BID; Type: EXPERIMENTAL; Interventions: Drug: CP- 690 550 | Arm Label: 3 mg BID; Type: EXPERIMENTAL; Interventions: Drug: CP- 690 550 | Arm Label: 0.5 mg BID; Type: EXPERIMENTAL; Interventions: Drug: CP- 690 550 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Intervention Type: DRUG; Name: CP- 690 550; Assigned to Arm(s): 15 mg BID | Intervention Type: DRUG; Name: CP- 690 550; Assigned to Arm(s): 10 mg BID | Intervention Type: DRUG; Name: CP- 690 550; Assigned to Arm(s): 3 mg BID | Intervention Type: DRUG; Name: CP- 690 550; Assigned to Arm(s): 0.5 mg BID | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): Placebo
B: Intervention Type: DRUG; Name: Infliximab; Assigned to Arm(s): N/A
C: Arm Label: 1: budesonide-MMX® 6 mg; Type: EXPERIMENTAL; Interventions: Procedure: Blood sampling, endoscopy, Drug: Budesonide MMX® 6 mg | Arm Label: 2: budesonide-MMX® 9 mg; Type: EXPERIMENTAL; Interventions: Procedure: Blood sampling, endoscopy, Drug: Budesonide MMX® 9 mg | Arm Label: 3: Entocort EC® 3 mg; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Blood sampling, endoscopy, Drug: Entocort EC® 3 mg | Arm Label: 4: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Blood sampling, endoscopy, Drug: Placebo | Intervention Type: PROCEDURE; Name: Blood sampling, endoscopy; Assigned to Arm(s): 1: budesonide-MMX® 6 mg, 2: budesonide-MMX® 9 mg, 3: Entocort EC® 3 mg, 4: Placebo | Intervention Type: DRUG; Name: Budesonide MMX® 6 mg; Assigned to Arm(s): 1: budesonide-MMX® 6 mg | Intervention Type: DRUG; Name: Budesonide MMX® 9 mg; Assigned to Arm(s): 2: budesonide-MMX® 9 mg | Intervention Type: DRUG; Name: Entocort EC® 3 mg; Assigned to Arm(s): 3: Entocort EC® 3 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 4: Placebo
D: Arm Label: 0.03 mg/kg or placebo iv; Type: OTHER; Interventions: Biological: Single dose-group A | Arm Label: 0.1 mg/kg or placebo iv; Type: OTHER; Interventions: Biological: Single dose-group A, Biological: Multiple dose- Group B | Arm Label: 0.3 mg/kg or placebo iv; Type: OTHER; Interventions: Biological: Single dose-group A, Biological: Multiple dose- Group B | Arm Label: 1.0 mg/kg or placebo iv; Type: EXPERIMENTAL; Interventions: Biological: Single dose-group A | Arm Label: 3.0 mg/kg or placebo sc; Type: OTHER; Interventions: Biological: Single dose-group A | Arm Label: 10 mg/kg or placebo iv; Type: OTHER; Interventions: Biological: Single dose-group A | Arm Label: 0.3 mg/kg or placebo sc; Type: OTHER; Interventions: Biological: Single dose-group A, Biological: Multiple dose-Group B | Arm Label: 0.1 mg/kg or placebo iv (multiple dose); Type: OTHER; Interventions: Biological: Multiple dose- Group B | Arm Label: 0.3 mg/kg or placebo iv (multiple dose); Type: OTHER; Interventions: Biological: Multiple dose- Group B | Arm Label: 3.0 mg/kg or placebo iv; Type: OTHER; Interventions: Biological: Multiple dose- Group B | Arm Label: 0.1 mg/kg or placebo sc; Type: OTHER; Interventions: Biological: Multiple dose- Group B | Arm Label: 0.3 mg/kg or placebo sc (multiple dose); Type: OTHER; Interventions: Biological: Multiple dose-Group B | Intervention Type: BIOLOGICAL; Name: Single dose-group A; Assigned to Arm(s): 0.03 mg/kg or placebo iv | Intervention Type: BIOLOGICAL; Name: Single dose-group A; Assigned to Arm(s): 0.1 mg/kg or placebo iv | Intervention Type: BIOLOGICAL; Name: Multiple dose- Group B; Assigned to Arm(s): 0.1 mg/kg or placebo iv (multiple dose) | Intervention Type: BIOLOGICAL; Name: Single dose-group A; Assigned to Arm(s): 0.3 mg/kg or placebo iv | Intervention Type: BIOLOGICAL; Name: Multiple dose- Group B; Assigned to Arm(s): 0.3 mg/kg or placebo iv (multiple dose) | Intervention Type: BIOLOGICAL; Name: Single dose-group A; Assigned to Arm(s): 1.0 mg/kg or placebo iv | Intervention Type: BIOLOGICAL; Name: Single dose-group A; Assigned to Arm(s): 3.0 mg/kg or placebo sc | Intervention Type: BIOLOGICAL; Name: Single dose-group A; Assigned to Arm(s): 10 mg/kg or placebo iv | Intervention Type: BIOLOGICAL; Name: Single dose-group A; Assigned to Arm(s): 0.3 mg/kg or placebo sc | Intervention Type: BIOLOGICAL; Name: Multiple dose-Group B; Assigned to Arm(s): 0.3 mg/kg or placebo sc | Intervention Type: BIOLOGICAL; Name: Multiple dose- Group B; Assigned to Arm(s): 0.1 mg/kg or placebo iv | Intervention Type: BIOLOGICAL; Name: Multiple dose- Group B; Assigned to Arm(s): 0.3 mg/kg or placebo iv | Intervention Type: BIOLOGICAL; Name: Multiple dose- Group B; Assigned to Arm(s): 3.0 mg/kg or placebo iv | Intervention Type: BIOLOGICAL; Name: Multiple dose- Group B; Assigned to Arm(s): 0.1 mg/kg or placebo sc | Intervention Type: BIOLOGICAL; Name: Multiple dose-Group B; Assigned to Arm(s): 0.3 mg/kg or placebo sc (multiple dose)

Answer: A